TrialAmerican journal of respiratory and critical care medicine2021

A Semimechanistic Model of the Bactericidal Activity of High-Dose Isoniazid against Multidrug-Resistant Tuberculosis: Results from a Randomized Clinical Trial.

Kamunkhwala Gausi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.